1. Home
  2. DFIN vs DRTS Comparison

DFIN vs DRTS Comparison

Compare DFIN & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Donnelley Financial Solutions Inc.

DFIN

Donnelley Financial Solutions Inc.

HOLD

Current Price

$38.69

Market Cap

991.6M

ML Signal

HOLD

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$10.57

Market Cap

978.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DFIN
DRTS
Founded
1983
2015
Country
United States
Israel
Employees
N/A
121
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
991.6M
978.2M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
DFIN
DRTS
Price
$38.69
$10.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$61.50
$8.67
AVG Volume (30 Days)
332.3K
975.6K
Earning Date
05-05-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.27
N/A
Revenue
$963,000,000.00
N/A
Revenue This Year
$4.98
N/A
Revenue Next Year
$3.87
$699.98
P/E Ratio
$31.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.07
$2.81
52 Week High
$66.25
$11.62

Technical Indicators

Market Signals
Indicator
DFIN
DRTS
Relative Strength Index (RSI) 34.28 58.06
Support Level $37.11 $6.59
Resistance Level $50.68 $11.62
Average True Range (ATR) 1.51 1.01
MACD 0.29 -0.12
Stochastic Oscillator 33.78 66.67

Price Performance

Historical Comparison
DFIN
DRTS

About DFIN Donnelley Financial Solutions Inc.

Donnelley Financial Solutions Inc is a risk and compliance software solutions and related services provider. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. It operates in four reportable segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management (its key revenue-generating segment), Investment Companies - Software Solutions, and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States (USA), Europe, Asia, Canada, and Others, of which the USA accounts for the vast majority of its total revenue.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: